Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Blocking both P-cadherin and c-Met can effectively stop head and neck cancer growth.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

CRH in the skin acts like the body's stress response system, affecting cell behavior and immune activity.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Hair relaxers and straighteners can be toxic to skin cells.

Alopecia areata is an autoimmune disease that targets hair follicles.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Loss of TET2 increases the risk of skin and oral cancer.

Ca²⁺-mediated protein citrullination controls cell growth in the CNS and may help treat brain tumors.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

ABCG2 protein marks stem-like skin cells in human epidermis.